Found 11296 clinical trials
-
Multi-country trial
-
Phase 1 trial
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For all genders
-
Neurology
-
Currently Recruiting
A Study to Evaluate the Safety Tolerability and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease
Parkinson's Disease (PD). The secondary objective of this study is to evaluate the pharmacokinetic (PK) profile of BIIB094.The study is open for PD patients with verified presence or absence of mutations in the
- 250 views
- 17 Nov, 2020
- 14 locations
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Oncology
-
Currently Recruiting
Advanced Breast Cancer with Visceral Metastases
People with advanced breast cancer are asked to participate in a research study being conducted by White Plains Hospital.
- 22 views
- 02 Aug, 2019
- 1 location
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
Phase II/III Study of Image-Guided Radiosurgery/SBRT For Localized Spine Metastasis
Phase II/III Study of Image-Guided Radiosurgery/SBRT For Localized Spine Metastasis
- 14 views
- 03 Dec, 2020
- 1 location
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
Pediatric Hyperparathyroidism & Chronic Kidney Disease
Children with Secondary Hyperparathyroidism & Chronic Kidney Disease are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.
- 57 views
- 18 Jan, 2019
- 1 location
-
Multi-country trial
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma
The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with metastatic merkel cell carcinoma (MCC).
- 101 views
- 14 Dec, 2020
- 7 locations
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (doxercalciferol capsules) in Pediatric Patients with Chronic Kidney Disease Stages 3 and 4 with Secondary Hyperparathyroidism Not Yet on Dialysis
This is a randomized, open label, parallel, active comparator study in patients aged 5– 18 years with Chronic Kidney Disease (CKD) Stages 3 and 4 and secondary hyperparathyroidism (SHPT) not
- 45 views
- 11 Jun, 2020
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients with Generalized Myasthenia Gravis IND 140,115 STUDY NUMBER: ALXN1210-MG-306
-ADL) profile. Secondary To assess the efficacy of ravulizumab compared with placebo in the treatment of gMG based on the improvement in the Quantitative Myasthenia Gravis
- 187 views
- 24 Nov, 2020
- 1 location
-
Multi-country trial
-
Phase 1 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
The purpose of this open-label nonrandomized Phase 1/2 study is to evaluate INCB001158 in combination with chemotherapy in participants with advanced/metastatic solid tumors.
- 38 views
- 14 Dec, 2020
- 13 locations
-
Multi-country trial
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
A PHASE 3 TRIAL OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
treatment withdrawal period. - To assess safety and tolerability. Key Secondary:
- 63 views
- 23 Nov, 2020
- 2 locations
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction
participants with Large Hemispheric Infarction (LHI). The secondary objectives are to determine if BIIB093 improves overall survival at Day 90 when compared with placebo, if BIIB093
- 12 views
- 12 Aug, 2020
- 1 location